The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
8 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,110,904 in first-year total cost, median $660,723.
Most frequent study sections
- AIDS Clinical Studies and Epidemiology Study Section[ACE]2
- Behavioral and Social Science Approaches to Preventing HIV/AIDS Study Section[BSPH]2
- Behavioral and Social Consequences of HIV/AIDS Study Section[BSCH]1
- Health Services Organization and Delivery Study Section[HSOD]1
- Social Psychology, Personality and Interpersonal Processes Study Section[SPIP]1
Most frequent institutions
- NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC.2
- DENVER HEALTH AND HOSPITAL AUTHORITY1
- JOHNS HOPKINS UNIVERSITY1
- UNIVERSITY OF CALIFORNIA, SAN DIEGO1
- UNIVERSITY OF ILLINOIS AT CHICAGO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial1R01DA042982-01A1 | HAUKOOS, JASONROWAN, SARAH ELIZABETH | DENVER HEALTH AND HOSPITAL AUTHORITY, CO | $652,668 | HSOD |
| 2017 | Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention1R01DA043409-01 | FARQUHAR, CAREYHERBECK, JOSHUA T | UNIVERSITY OF WASHINGTON, WA | $668,778 | ACE |
| 2017 | Contextual risk factors for hepatitis C among young persons who inject drugs1R01DA043484-01A1 | BOODRAM, BASMATTEE | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $539,772 | SPIP |
| 2016 | The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors1R01DA041501-01A1 | GUARINO, HONORIA MMATEU-GELABERT, PEDRO | NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC., NY | $761,598 | BSPH |
| 2016 | Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care1R01DA041298-01 | MARKS, KRISTEN MMATEU-GELABERT, PEDRO | NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC., NY | $594,712 | BSPH |
| 2015 | RCT of a social-network oriented mhealth based intervention to increase access and adherence to HCV treatment and HIV viral suppression1R01DA040488-01 | LATKIN, CARL ATOBIN, KARIN E | JOHNS HOPKINS UNIVERSITY, MD | $726,936 | BSCH |
| 2015 | Impact of HCV Therapy on CNS Outcomes1R01DA039775-01 | BHARTI, AJAY R | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $689,684 | ZRG1 |
| 2015 | A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (the REACT Study)1R01DA040506-01 | MATTHEWS, GAIL | UNIVERSITY OF NEW SOUTH WALES | $476,756 | ACE |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.